GNH USA

Europe — EMA

Octaplex

GNH USA supplies Octaplex (Human Coagulation Factors), a blood coagulation factor concentrate for managing complex bleeding disorders.

Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F

Request sourcing

1
Pack/s

What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Human Coagulation Factor Ix, Protein C, Human Coagulation Factor VII, Protein S, and Human Coagulation F, the active ingredients in Octaplex, is a blood coagulation factor concentrate presented as a sterile injectable solution for intravenous use. It is used to manage bleeding disorders related to multiple coagulation factor deficiencies. GNH USA supplies Octaplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Octaplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F used for?

Octaplex is a multi‑factor concentrate that addresses disorders of the coagulation cascade.

- Congenital deficiency of multiple coagulation factors: provides replacement therapy to control bleeding. - Acquired coagulopathy during major surgery or trauma: supports hemostasis when multiple factors are depleted. - Liver disease‑related coagulopathy: supplies deficient factors to improve clot formation. - Hemophilia A or B with inhibitors: offers an alternative when standard factor concentrates are ineffective. - Peri‑operative management for patients with complex factor deficiencies: ensures adequate hemostasis during invasive procedures.

What are the side effects of Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Octaplex may cause adverse reactions ranging from mild to severe.

Common Side Effects: - Fever - Headache - Mild infusion‑related erythema - Transient hypotension - Nausea - Fatigue

Serious or Rare Side Effects: - Anaphylactic reaction - Severe thromboembolic events - Disseminated intravascular coagulation (DIVC) - Acute hemolysis - Severe hypersensitivity including serum sickness - Renal impairment secondary to hemolysis

What precautions apply to Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

When using Octaplex, clinicians should consider several safety measures.

- Monitor coagulation parameters: regular PT/INR and aPTT testing guides dosing. - Assess for inhibitor development: watch for reduced efficacy over time. - Evaluate liver function: impaired metabolism may affect factor levels. - Use caution in patients with a history of thrombosis: increased clot risk. - Avoid rapid infusion rates: reduce risk of hypotension and reactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F interact with?

Octaplex can interact with other agents that affect hemostasis or immune response.

Major Interactions (Avoid): - Concomitant use of high‑dose anticoagulants (e.g., warfarin, direct oral anticoagulants) may counteract the clotting effect. - Activated protein C concentrates — may diminish therapeutic benefit.

Moderate Interactions (Monitor Closely): - Immunosuppressive biologics: may increase risk of inhibitor formation. - Antibiotics such as vancomycin that can cause infusion reactions. - Antifibrinolytics (tranexamic acid) used together may increase thrombosis risk. - Cytokine‑targeting therapies: may alter immune response to the product. - Vaccines administered within 24 h of infusion: monitor for heightened immune reactions.

Frequently asked questions

What is Octaplex used for?+
Octaplex is a multi‑factor blood‑coagulation concentrate used to replace deficient clotting proteins in patients with complex or multiple factor deficiencies, such as congenital disorders, acquired coagulopathy during surgery, or liver‑related bleeding disorders. It helps achieve hemostasis when standard single‑factor products are insufficient.
How does the active ingredient in Octaplex work?+
The product supplies human coagulation factors II, VII, IX, X together with regulatory proteins Protein C and Protein S. After intravenous infusion, these proteins re‑establish the normal cascade that converts prothrombin to thrombin, leading to fibrin formation and stable clot development.
What is the usual dose of Octaplex?+
Dosing is individualized. The prescribing clinician determines the amount and frequency based on the patient’s specific factor deficiencies, weight, severity of bleeding and laboratory coagulation results. No fixed regimen is provided in public literature.
Is Octaplex safe to use during pregnancy or breastfeeding?+
Human coagulation factor concentrates are generally considered low risk because they are purified proteins, but safety data in pregnancy and lactation are limited. Use should be limited to situations where the benefit outweighs potential risk, and decisions are made by the treating obstetric and hematology specialists.
How do I order Octaplex from GNH USA?+
To request Octaplex, submit an enquiry on the product page at gnh-usa.com indicating the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.
How does Octaplex compare with other coagulation products?+
Octaplex provides a combination of several clotting factors in one vial, which can be advantageous over single‑factor concentrates when multiple deficiencies exist. Compared with plasma‑derived products, it offers a more concentrated, virus‑inactivated preparation, reducing volume load and infection risk, though cost and availability may differ.
What are the storage and handling requirements for Octaplex?+
Octaplex must be stored refrigerated at 2 °C to 8 °C, protected from light, and should never be frozen or shaken. Prior to use, allow the vial to reach room temperature if required, and inspect for particulate matter or discoloration before administration.
How is Octaplex administered?+
Octaplex is supplied as a sterile liquid for intravenous infusion. It is administered by a qualified healthcare professional, typically through a controlled infusion set, with infusion rates adjusted according to patient tolerance and clinical response.
What are the most serious risks associated with Octaplex?+
Serious adverse events include anaphylaxis, severe thromboembolic complications, disseminated intravascular coagulation, acute hemolysis and renal impairment. Immediate medical attention is required if any signs of severe hypersensitivity or unexpected clotting occur.
Who should not receive Octaplex?+
Octaplex is contraindicated in patients with known hypersensitivity to any of its protein components or to the stabilising excipients, and in individuals with a history of severe thrombotic events unless the benefit clearly outweighs the risk. Clinical judgement is essential for each case.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F
Route
Intravenous Use
Manufacturer
Octapharma As
Origin
EU